AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 805.60 | 813.56 | 831.81 | 728.29 | 571.00 |
| Expenses | |||||
| Material consumed | 311.96 | 297.98 | 307.86 | 234.28 | 183.64 |
| Manufacturing expenses | - | 7.37 | 7.72 | 8.27 | 8.30 |
| Personnel expenses | 230.21 | 219.54 | 216.70 | 197.40 | 153.53 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 177.26 | 153.20 | 178.83 | 217.04 | 179.24 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 719.43 | 678.09 | 711.11 | 656.99 | 524.71 |
| Operating profit | 86.17 | 135.47 | 120.70 | 71.30 | 46.29 |
| Other recurring income | 14.76 | 12.84 | 12.99 | 16.29 | 12.25 |
| Adjusted PBDIT | 100.93 | 148.31 | 133.69 | 87.59 | 58.54 |
| Financial expenses | 0.95 | 1.09 | 1.14 | - | - |
| Depreciation | 16.95 | 20.13 | 18.58 | 14.92 | 14.74 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 83.04 | 127.09 | 113.97 | 72.67 | 43.80 |
| Tax charges | 21.44 | 33.79 | 41.76 | 18.22 | 17.89 |
| Adjusted PAT | 61.59 | 93.30 | 72.21 | 54.45 | 25.91 |
| Non recurring items | - | 3.43 | -4.92 | -0.60 | -2.28 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 61.59 | 96.73 | 67.29 | 53.85 | 23.63 |
| Earnigs before appropriation | 61.59 | 329.10 | 235.38 | 168.22 | 114.37 |
| Equity dividend | - | 5.00 | 1.99 | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | 0.51 | - | - |
| Retained earnings | 61.59 | 324.10 | 232.88 | 168.22 | 114.37 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis